Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Dec;83(6):709-737.
doi: 10.1016/j.jinf.2021.08.045. Epub 2021 Sep 2.

The high expression of SARS-CoV-2 cell receptors might lead to higher COVID-19 infection rates in cancer patients

Shizheng Qiu  1 , Yu Zhang  2 , Donghua Wang  3 , Yang Hu  4
Affiliations
Comment

The high expression of SARS-CoV-2 cell receptors might lead to higher COVID-19 infection rates in cancer patients

Shizheng Qiu et al. J Infect. 2021 Dec.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The expression levels of all known SARS-COV-2 receptors in four types of tumor patients that might more likely be infected by COVID-19. * P  < 0.05; ** P< 0.01; *** P< 0.001. (A) Lung cancer; (B) B-cell lymphoma; (C) Leukemia; (D) Esophageal carcinoma.
See this image and copyright information in PMC

Comment on

References

    1. Cai C., Ahmed O.A., Shen H., Zeng S. Which cancer type has the highest risk of COVID-19 infection? J Infect. 2020;81(4):647–679. OctPubMed PMID: 32442454. Pubmed Central PMCID: PMC7235576. Epub 2020/05/23. - PMC - PubMed
    1. Aguiar J.A., Tremblay B.J., Mansfield M.J., Woody O., Lobb B., Banerjee A., et al. Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue. Eur Respir J. 2020;56(3) SepPubMed PMID: 32675206. Pubmed Central PMCID: PMC7366180 B.J-M. Tremblay has nothing to disclose. Conflict of interest: M.J. Mansfield has nothing to disclose. Conflict of interest: O. Woody has nothing to disclose. Conflict of interest: B. Lobb has nothing to disclose. Conflict of interest: A. Banerjee has nothing to disclose. Conflict of interest: A. Chandiramohan has nothing to disclose. Conflict of interest: N. Tiessen has nothing to disclose. Conflict of interest: Q. Cao has nothing to disclose. Conflict of interest: A. Dvorkin-Gheva has nothing to disclose. Conflict of interest: S. Revill has nothing to disclose. Conflict of interest: M.S. Miller has nothing to disclose. Conflict of interest: C. Carlsten has nothing to disclose. Conflict of interest: L. Organ has nothing to disclose. Conflict of interest: C. Joseph has nothing to disclose. Conflict of interest: A. John has nothing to disclose. Conflict of interest: P. Hanson has nothing to disclose. Conflict of interest: R. Austin has a patent US7524826B2 issued to McMaster University and Hamilton Health Sciences Corp., McMaster University. Conflict of interest: B.M. McManus has nothing to disclose. Conflict of interest: G. Jenkins reports grants from AstraZeneca, Biogen, Galecto and GlaxoSmithKline; personal fees from Boehringer Ingelheim, Daewoong, Galapagos, Heptares, Promedior and Roche; grants and personal fees from Pliant; non-financial support from Redx and NuMedii; and is trustee for Action for Pulmonary Fibrosis, outside the submitted work. Conflict of interest: K. Mossman has nothing to disclose. Conflict of interest: K. Ask has nothing to disclose. Conflict of interest: A.C. Doxey has nothing to disclose. Conflict of interest: J.A. Hirota has nothing to disclose. Epub 2020/07/18. - PMC - PubMed
    1. Grant R.A., Morales-Nebreda L., Markov N.S., Swaminathan S., Querrey M., Guzman E.R., et al. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. Nature. 2021;590(7847):635–641. FebPubMed PMID: 33429418. Pubmed Central PMCID: PMC7987233. Epub 2021/01/12. - PMC - PubMed
    1. Zhu S., Liu Y., Zhou Z., Zhang Z., Xiao X., Liu Z., et al. Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry. Sci China Life Sci. 2021 Aug 20. PubMed PMID: 34431042. Epub 2021/08/26. - PMC - PubMed
    1. Baggen J., Persoons L., Vanstreels E., Jansen S., Van Looveren D., Boeckx B., et al. Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2. Nat Genet. 2021;53(4):435–444. AprPubMed PMID: 33686287. Epub 2021/03/10. - PubMed